FDA Drug Recalls

Recalls / Class II

Class IID-0410-2026

Product

EYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) bottles, Sterile; a) Walgreens, DISTRIBUTED BY: WALGREEN CO., DEERFIELD, IL 60015; UPC 3 11917 20074 3; b) Kroger, DISTRIBUTED BY THE KROGER CO., CINCINNATI, OHIO 45202; c) CVS Health, Distributed by :CVS Pharmacy, Inc., Woonsocket, RI 02895, UPC 0 50428 43544 1; d) QC-Quality Choice, Distributed by: CDMA, Inc., Novi, MI 48375, NDC 83324-191-14; e) Discount drug mart, Discount Drug Mart Food Fair, Medina, OH 44256, UPC 0 93351 01155 9; f) Foster & Thrive, Distributed by: McKesson Corp., via SSSL, Memphis, TN 38141, NDC 70677-1158-1; g) GoodSense, Distributed By: Perrigo Direct Inc., Peachtree City, GA 30269, www.PerrigoDirect.com, NDC 50804-130-01; h) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 03641 3; I) DG health Sterile, DISTRIBUTED BY OLD EAST MAIN CO., 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072, UPC 0 95072 02556 3; j) Fast Acting, CODE RED Eye Drops, Sterile, Distributed by: 4 Trees, LLC, NDC 83817-963-01.

Brand names
Quality Choice Moisturizing Relief Eye Drops, Foster And Thrive Advanced Relief Eye Drops, Goodsense Eye Drops Advanced Relief Moisturizer, Code Red Eye Drops Redness Relief
Generic names
Dextran 70, Polyethylene Glycol 400, Povidone, Tetrahydrozoline Hcl, Polyethylene Glycol 400, Tetrahydrozoline Hcl, Dextran, Polyethylene Glycol 400, Povidone, Tetrahydrozoline Hcl
Active ingredients
Dextran 70, Polyethylene Glycol 400, Povidone, Tetrahydrozoline Hydrochloride
Route
Ophthalmic
NDCs
83324-191, 70677-1158, 50804-130, 83817-963
FDA application
M018
Affected lot / code info
Lot: a) AR24D01, Exp.: 04/30/26; AR24G01, AR24G02, Exp.: 07/31/26; AR24M01, Exp.: 10/31/26; b) AR24D01, Exp.: 04/30/26; AR24G01, Exp.: 07/31/26; AR24M01, Exp.: 10/31/26; c) AR24D01, Exp.: 04/30/26; AR24G02, Exp.: 07/31/26; AR24M01, Exp.: 10/31/26; d) AR24G02, Exp.: 07/31/26; e) AR24G02, Exp.: 07/31/26; f) AR24G02, Exp.: 07/31/26; g) AR24M01, Exp.: 10/31/26, h) AR24G01, Exp.: 07/31/26; AR24M01, Exp.:10/31/26; I) AR24M01, Exp.:10/31/26; j) AR24D01, Exp.: 04/30/26.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
K.C. Pharmaceuticals, Inc
Manufacturer
Chain Drug Marketing Association, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
3420 Pomona Blvd, Pomona, California 91768-3236

Distribution

Quantity
303,216 bottles
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2026-03-03
FDA classified
2026-03-31
Posted by FDA
2026-04-08
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0410-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.